Platelet-rich plasma vs corticosteroids for elbow epicondylitis A systematic review and meta-analysis

被引:43
|
作者
Li, Ang [1 ]
Wang, Hongbo [1 ,2 ]
Yu, Zhenghong [1 ]
Zhang, Guangquan [1 ]
Feng, Shiqing [3 ]
Liu, Liyun [1 ]
Gao, Yanzheng [1 ]
机构
[1] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Orthoped, Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China
[2] Henan Univ, Peoples Hosp, Zhengzhou, Henan, Peoples R China
[3] Tianjin Med Univ, Dept Orthoped, Gen Hosp, Tianjin, Peoples R China
关键词
corticosteroids; epicondylitis; meta-analysis; platelet-rich plasma; RANDOMIZED CONTROLLED-TRIAL; LATERAL EPICONDYLITIS; DOUBLE-BLIND; INJECTION THERAPIES; TENNIS ELBOW; CONCENTRATE; MANAGEMENT; EFFICACY;
D O I
10.1097/MD.0000000000018358
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this meta-analysis was to compare the effectiveness of platelet-rich plasma (PRP) vs corticosteroids for treatment of patients with lateral elbow epicondylitis. Methods: A literature search was performed in EMBASE, Medline, the Cochrane Library and PubMed. Randomized controlled studies comparing PRP with corticosteroids for the treatment of epicondylitis were included. The Cochrane Collaboration's tool for assessing the risk of bias was used to evaluate the methodological quality of the included trials. The Cochrane Collaboration's Review Manager software was used to perform the meta-analyses. The overall effect size of each anesthetic was calculated as the weighted average of the inverse variance of the study-specific estimates. Results: Seven randomized controlled trials were included in this review. The data from 2 studies were unavailable for meta-analysis, and the systematic review criteria were just achieved. Local corticosteroid injection yielded a significantly superior Disabilities of the Arm, Shoulder and Hand (DASH) score at 4 weeks (WMD, 11.90; 95% CI: 7.72 to 16.08; P < .00001; heterogeneity, chi(2) = 0, I-2 = 0%, P = 1.00) and 8 weeks (WMD, 6.29; 95% CI: 2.98 to 9.60; P = .0002, chi(2) = 0, I-2 = 0%, P = 1.00). Otherwise, it was noteworthy that a significantly lower VAS score (WMD, -2.61; 95% CI: -5.18 to -0.04; P = .05; heterogeneity, chi(2) = 29.85, I-2 = 97%, P < .00001) and DASH score (WMD, -7.73; 95% CI: -9.99 to -5.46; P < .00001, chi(2) = 0.20, I-2 = 0%, P = .66) existed in the PRP regimen than in the steroid regimen at the 24-week follow-up. More effective treatments were achieved in the PRP-treated patients than in the patients treated with corticosteroids (WMD, 3.33; 95% CI: 1.81 to 6.14; P = .000; heterogeneity, chi(2) = 0.43, I-2 = 0%, P = .51). Conclusions: Local corticosteroid injections demonstrated favorable outcomes compared with those of local PRP treatments for lateral elbow epicondylitis during the short-term follow-up period (4 weeks and 8 weeks post-treatment). Otherwise, at the long-term follow-up (24 weeks post-treatment), PRP injections had improved pain and function more effectively than corticosteroid injections.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Platelet-rich plasma injection in the treatment of patellar tendinopathy: a systematic review and meta-analysis
    Apurba Barman
    Mithilesh K. Sinha
    Jagannatha Sahoo
    Debasish Jena
    Vikas Patel
    Suman Patel
    Souvik Bhattacharjee
    Debanjan Baral
    Knee Surgery & Related Research, 34
  • [32] Platelet-rich plasma injection for the treatment of ankle osteoarthritis: a systematic review and meta-analysis
    Sukij Laohajaroensombat
    Suwimol Prusmetikul
    Sasivimol Rattanasiri
    Ammarin Thakkinstian
    Patarawan Woratanarat
    Journal of Orthopaedic Surgery and Research, 18
  • [33] Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis
    Laudy, Augustinus B. M.
    Bakker, Eric W. P.
    Rekers, Mark
    Moen, Maarten H.
    BRITISH JOURNAL OF SPORTS MEDICINE, 2015, 49 (10) : 657 - 672
  • [34] Platelet-Rich Plasma in Female Androgenic Alopecia: A Comprehensive Systematic Review and Meta-Analysis
    Zhou, Shuying
    Qi, Fei
    Gong, Yue
    Zhang, Chenxi
    Zhao, Siqi
    Yang, Xutong
    He, Yanling
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [35] Platelet-rich plasma treatment for talar cartilage repair: a systematic review and meta-analysis
    Jialei Peng
    Qian Wang
    Yang Xu
    Hongchen He
    BMC Musculoskeletal Disorders, 24
  • [36] The use of platelet-rich plasma in wound healing and vitiligo: A systematic review and meta-analysis
    Wang, Zhi
    Feng, Cheng
    Chang, Guojing
    Liu, Hao
    Li, Shuo
    SKIN RESEARCH AND TECHNOLOGY, 2023, 29 (09)
  • [37] The Effectiveness and Safety of Platelet-Rich Plasma for Chronic Wounds: A Systematic Review and Meta-analysis
    Qu, Wenchun
    Wang, Zhen
    Hunt, Christine
    Morrow, Allison S.
    Urtecho, Meritxell
    Amin, Mustapha
    Shah, Sahrish
    Hasan, Bashar
    Abd-Rabu, Rami
    Ashmore, Zack
    Kubrova, Eva
    Prokop, Larry J.
    Murad, Mohammad Hassan
    MAYO CLINIC PROCEEDINGS, 2021, 96 (09) : 2407 - 2417
  • [38] Efficacy of platelet-rich plasma as conservative treatment in orthopaedics: a systematic review and meta-analysis
    Franchini, Massimo
    Cruciani, Mario
    Mengoli, Carlo
    Marano, Giuseppe
    Pupella, Simonetta
    Veropalumbo, Eva
    Masiello, Francesca
    Pati, Ilaria
    Vaglio, Stefania
    Liumbruno, Giancarlo M.
    BLOOD TRANSFUSION, 2018, 16 (06) : 502 - 513
  • [39] Rejuvenating the periorbital area using platelet-rich plasma: a systematic review and meta-analysis
    Evans, Adam G.
    Ivanic, Mirjana G.
    Botros, Mina A.
    Pope, Rand W.
    Halle, Briana R.
    Glassman, Gabriella E.
    Genova, Rafaella
    Al Kassis, Salam
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2021, 313 (09) : 711 - 727
  • [40] Platelet-rich plasma for treating dry eye disease - A systematic review and meta-analysis
    Akowuah, Prince Kwaku
    Obinwanne, Chukwuemeka Junior
    Owusu, Ebenezer
    Kyeremeh, Sylvester
    Bonsu, Kwaku
    Karikari, Lucy Akua Afriyie
    Akomeah, Felicia Akyaa
    Nkansah, Ernest Kyei
    Kobia-Acquah, Emmanuel
    CONTACT LENS & ANTERIOR EYE, 2024, 47 (01):